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Background and aims: Spontaneous gastric perforation in the absence of chemotherapy is extremely rare. The
authors encountered a case of spontaneous perforation of primary gastric lymphoma.
Case presentation: A 58-year-old man visited the authors’ hospital with acute severe epigastralgia. A large amount
of free gas and a fluid collection around the stomach were noted on an abdominal computed tomography scan.
The results of imaging studies indicated a perforated gastric ulcer, and a distal gastrectomy was performed. There
was a large perforation about 50 mm in diameter in the anterior wall of the middle part of the stomach body.
Microscopically, the full thickness of the gastric wall was diffusely infiltrated by a population of large atypical
lymphoid cells. The lymphoid nature of these cells was indicated by the strongly positive immunohistochemical
staining for CD20 and CD10. This confirmed the diagnosis of a germinal center B-cell-like type of diffuse large
B cell lymphoma. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone were administered
after the operation.
Results and conclusion: Gastrectomy should be considered if a giant ulcer with necrotic matter on the ulcer floor
is seen on upper gastrointestinal endoscopy because of the possibility of gastric perforation. If upper
gastrointestinal endoscopy shows a finding similar to the abovementioned one during chemotherapy, dose
reduction of chemotherapy or gastrectomy should be considered.
Keywords: Spontaneous perforation, Gastric malignant lymphoma, Distal gastrectomy, Diffuse large B cell
lymphoma, Emergency, Necrotic matterBackground
Gastrointestinal non-Hodgkin lymphoma is the most
common form of extranodal lymphoma. The vast major-
ity of gastric lymphomas are extranodal marginal zone B
cell lymphomas of mucosa-associated lymphoid tissue
(MALT lymphoma) and diffuse large B cell lymphoma
(DLBCL), which were previously considered as low-grade
and high-grade gastric lymphomas, respectively [1-3].
Primary gastric lymphoma is rare, accounting for only
1%–5% of all gastric tumors [4,5].* Correspondence: yu.ohkura107@gmail.com
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unless otherwise stated.Perforation of the gastric malignant lymphoma during
chemotherapy is a well-known event. However, the inci-
dence is not high. Furthermore, spontaneous gastric per-
foration in the absence of chemotherapy is extremely
rare. In recent years, the standard therapy for aggressive
gastric lymphoma has shifted from surgery to chemo-
therapy and medical therapy. Primary surgical resection
is no longer the standard of care. However, it is difficult
to make a preoperative diagnosis of spontaneous perfor-
ation of primary gastric lymphoma. The authors en-
countered a case of spontaneous perforation of primary
gastric lymphoma, and it was considered in terms of
pathological findings.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Abdominal CT scan. The site of gastric perforation at the
anterior wall of the body of the stomach was identified. There were
free gas and fluid collections around the stomach, liver, and spleen.
Figure 2 Laparoscopic visualization of the abdominal cavity.
There was a large perforation about 50 mm in size in the anterior
wall of the middle part of the stomach body (arrow) with purulent
ascites and a large amount of food residue.
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On 6 November 2008, a 53-year-old man presented to a
nearby hospital with the chief complaints of epigastric
pain and black stool. Upper gastrointestinal endoscopy
revealed a large deep ulceration in the gastric antrum.
Enhanced abdominal computed tomography (CT) scan
showed multiple enlarged para-aortic lymph nodes. The
other lymph nodes were not enlarged. Positron emission
tomography/CT showed abnormal accumulations of fluor-
odeoxyglucose in the gastric angle, para-aortic lymph
nodes, pelvic lymph nodes, and prostate. They suspected
malignant lymphoma or prostate cancer. The prostate bi-
opsy showed prostate cancer, and a definitive diagnosis of
gastric malignant lymphoma could not be made despite
gastric biopsies that were performed every 6 months.
There were no abnormal findings in the bone marrow bi-
opsy. Because of the high-serum level of prostate-specific
antigen (833 ng/ml) and prostate capsular invasion on
magnetic resonance imaging (MRI), they made the diag-
nosis of metastasis of prostate cancer to the para-aortic
and pelvic lymph nodes (cT3aN1M1). Treatment was ini-
tiated for the prostate cancer rather than the gastric
malignant lymphoma. They started medical therapy for
prostate cancer (bicalutamide and leuprorelin acetate).
After medical therapy, enhanced abdominal CT showed
that the para-aortic and pelvic lymph nodes had become
progressively smaller and the level of prostate specific
antigen had decreased. On the other hand, upper gastros-
copy showed that the gastric tumor had enlarged grad-
ually. Once control of prostate cancer was achieved, they
had planned to start medical treatment for the gastric
tumor. The presence of Helicobacter pylori infection was
demonstrated by the positive results of histologic examin-
ation, rapid urease test, and serology. They performed H.
pylori eradication therapy.
In November 2013, the patient visited the authors’
hospital with acute abdominal pain. He had severe
epigastralgia that had started after breakfast. He was
58 years old, 166-cm tall and weighed 62 kg, with a body
temperature of 35.9°C, a pulse rate of 81 beats/min, and
a blood pressure of 127/82 mmHg. On physical examin-
ation, abdominal distension and severe tenderness were
present. Blood tests showed normal results for the white
blood cell count (4,900/μl), C-reactive protein (0.1 mg/
dl), lactate dehydrogenase (200 IU/l), and interleukin-2
receptor (264 U/ml). Abdominal CT scan showed a large
amount of intraperitoneal free gas and a fluid collection
around the stomach, liver, and spleen. Also, the site of
gastric perforation at the anterior wall of the body of the
stomach was identified (Figure 1). A diagnosis of perfor-
ation of gastric ulcer and pan-peritonitis was made, but
details of the gastric lymphoma were unknown because
it was his first visit to the authors’ hospital. The results
of imaging studies indicated a perforated gastric ulcer,and an emergency operation was performed. At first, a
laparoscopic omental implantation repair was planned.
On laparoscopic visualization of the abdominal cavity,
purulent ascites and food residue were observed. There
was a large perforation about 50 mm in diameter in the
anterior wall of the middle part of the stomach body
(Figure 2). Because a large amount of food residue had
escaped through the large perforation, removal of the
Figure 4 Histological specimen. The full thickness of the gastric
wall was diffusely infiltrated by a population of large, atypical
lymphoid cells. Tumor cells and necrotic matter were seen around the
perforation and ulcer floor (hematoxylin & eosin staining; ×1.25, ×60).
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attempted but it was unsuccessful. Therefore, an emer-
gency laparotomy was performed. A distal subtotal gas-
trectomy with Roux-en-Y anastomosis and lymph node
dissection was performed. Macroscopically, the gastric
ulcer was 4.2 × 1.5 cm in size, and the perforation was
4.0 × 1.3 cm in size and located on the anterior wall of
the gastric antrum (Figure 3a, b). It was ulcerative and
infiltrative and was the excavated type according to
Sano’s classification [2]. Microscopically, a population of
large atypical lymphoid cells diffusely infiltrated the full
thickness of the gastric wall. Tumor cells were mainly
centroblasts. Tumor cells diffusely infiltrated the muscle
and subserosal layers (Figure 4). Tumor cells and nec-
rotic matter were detected around the perforation and
ulcer floor. The lymphoid nature of these cells was con-
firmed by the strong positive immunohistochemical
staining for CD20, CD38, and CD10; the slightly positive
staining for Bcl-6; and partial positivity for MUM-1 (Fig-
ure 5). On the other hand, the results for CD3, CD5,
Bcl-2, and EBER ISH were negative. The MIB-1 labelingFigure 3 Resected specimen and macroscopic appearance of
the tumor. (a) Resected specimen. (b) Macroscopic appearance
of the tumor. The gastric ulcer was 4.2 × 1.5 cm in size while the
perforation was 4.0 × 1.3 cm in size, and they were located on the
anterior wall of the gastric antrum.index was about 80%. These findings confirmed the diag-
nosis of germinal center B-cell-like type of DLBCL. There
was no evidence of a low-grade MALT lymphoma. The
number of metastatic lymph nodes was 3/31. Based on
the Lugano International Classification, the stage was
II1E (perforation and pan-peritonitis) since lymph node
metastasis was present around the left gastric artery and
greater curvature of the stomach and distant metastasis
was absent.Figure 5 Immunohistochemical staining. The lymphoid nature of
these cells was indicated by the strong positive immunohistochemical
staining for CD20, CD38, and CD10 and negative staining for CD5. The
MIB-1 labeling index was about 80% (×60).
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discharged from hospital 16 days postoperatively. He was
administered rituximab plus cyclophosphamide, doxorubi-
cin, vincristine, and prednisone (R-CHOP) therapy at the
previous hospital.
Conclusions
Malignant lymphoma of the gastrointestinal tract can be
classified as nodal or extranodal. Nodal lymphomas ori-
ginate in the lymphatic tissue adjacent to the gastrointes-
tinal tract and invade it, whereas extranodal lymphomas,
which are more common, originate in the gastrointestinal
tract [3]. Dawson et al. [4] described five major features as
the criteria for primary malignant lymphoma of the intes-
tinal tract: 1) no palpable superficial lymphadenopathy, 2)
no enlarged mediastinal lymph nodes evident on chest ra-
diographs, 3) normal total and differential white blood cell
counts, 4) prominent bowel lesions at laparotomy, and 5)
no tumors in the liver or spleen. The patient had a large
ulcer in the stomach, and infiltration of other organs wasTable 1 Literature reviewed







1985 42 Male U 32 5
2 Ando
et al. [13]
1992 22 Male L 15 ND
3 Yanagi
et al. [14]
1992 65 Male L 185 25
4 Shiomi
et al. [15]
1997 71 Male M 150 20
5 Fukuda
et al. [16]
1998 45 Male M 90 7
6 Miyamoto
et al. [17]
1999 46 Male ML 30 6
7 Yabuki
et al. [3]
2000 53 Male M 100 10
8 Mori
et al. [18]
2005 65 Female U 30 ND
9 Tanaka
et al. [19]
2007 84 Female M 90 ND
10 Matsunaga
[20]
2008 73 Male M 135 3
11 Saito
et al. [21]
2010 67 Female ML 85 ND
12 Ishimaru and
Kitsukawa [22]
2011 54 Female M 200 5
13 Sunagawa
et al. [23]
2011 91 Female M 120 8
14 Shimada
et al. [24]
2013 85 Female L 65 30
15 Present case 2013 58 Male M 42 40
U upper, M middle, L lower, ND no description, DG distal gastrectomy, TG total gast
lymphoid tissue lymphoma.not found. The present case met all of the abovemen-
tioned criteria, so this case was considered to be primary
gastric lymphoma. Primary gastric lymphoma is rare, ac-
counting for only 1%–5% of all gastric tumors [5].
In recent years, the standard treatment for aggressive
gastric lymphoma has shifted from surgery to chemother-
apy. The treatment varies with the histology of the malig-
nant lymphoma. First-line chemotherapy for DLBCL of
the stomach is CHOP with or without rituximab. On the
other hand, antibiotic treatment to eradicate H. pylori is
the first-line therapy for MALT lymphoma. Bayerdolffer
et al. [6] reported that about 70% of patients showed
complete regression and about 12% had partial regression
of lymphoma but 18% had no change after eradication of
H. pylori infection. Radiation treatment for H. pylori-nega-
tive gastric MALT lymphoma has a high-success rate of
90% or better after 5 years. Also, there were some reports
strongly supporting the hypothesis that some gastric de
novo H. pylori-positive DLBCL might remain H. pylori-




Operation Pathology Lugano Adjuvant
chemotherapy
Excavated DG Burkitt II1E +
Ulcerative DG DLBCL IIE +
Excavated DG DLBCL II1E +
Excavated TG DLBCL II2E +
Excavated DG DLBCL II1E +
Ulcerative DG MALT IIE −
Excavated DG DLBCL IIE +
Ulcerative TG DLBCL IV +
Excavated DG DLBCL II2E +
Ulcerative TG DLBCL II1E +
Excavated DG DLBCL IIE +
Excavated TG DLBCL II1E +
Excavated DG DLBCL II1E −
Ulcerative TG DLBCL II1E −
Excavated DG DLBCL II1E +
rectomy, DLBCL diffuse large B cell lymphoma, MALT mucosa-associated
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ence of H. pylori infection was indicated by the positive
results of the histologic examination, rapid urease test,
and serology. Despite H. pylori eradication therapy in
the present case, there was no size reduction of the gas-
tric malignant lymphoma.
Primary gastric lymphoma often presents with non-
specific symptoms, and the diagnosis is often delayed.
Nonspecific abdominal pain (50%) and dyspepsia (30%) are
the most common presentations. B symptoms (fever, night
sweat, and weight loss) are uncommon in contrast to nodal
lymphomas; thus, the diagnosis might be delayed [9].
It is widely known that perforation occasionally occurs
in patients receiving chemotherapy. Yoshino et al. [10]
and Maisey et al. [11] reported that perforation of gastric
lymphoma in patients receiving chemotherapy occurs in
about 0.9% to 1.1% of cases. On the other hand, spon-
taneous perforation of malignant gastric lymphoma is
rare compared with perforation of gastric lymphoma in
patients receiving chemotherapy. Table 1 shows 15 cases
of spontaneous perforation of primary gastric lymphoma
that required gastrectomy in Japan between 1985 and
2013 [3,12-24]. Of these 15 patients, nine were men and
six were women with an age range from 22 to 91 years
and a mean age of 61.4 years. The mean tumor size was
91.3 mm (15–200 mm), and the mean diameter of the
perforation was 14.5 mm (3–40 mm). Patients with spon-
taneous perforation of primary gastric lymphoma requir-
ing gastrectomy had larger tumors and perforations. The
present patient had the largest perforation out of those in
past reports.
The cause of perforation of gastric lymphoma in cases
receiving chemotherapy is different from those in cases
that did not receive chemotherapy. Ono et al. [25] re-
ported that the causes of perforation in patients receiv-
ing chemotherapy are weakening of the gastric tissue
associated with rapid tumor necrosis, tumor lysis, and
exuberant granulation due to chemotherapy. On the
other hand, Shiomi et al. [15] reported that there are
two different patterns of spontaneous perforation. First,
the spontaneous perforation results from an ulcer and
tumor necrosis that has reached the subserosa. Second,
the perforation results from an ulcer that has thin con-
nective tissue with the absence of tumor. In the present
case, tumor cells and necrotic matter were seen micro-
scopically around the ulcer floor and perforation site, so
it was considered that spontaneous perforation resulted
from the existence of an ulcer and necrosis of the tumor
that had reached the subserosa.
It is difficult to make a preoperative diagnosis of spon-
taneous perforation of primary gastric lymphoma. In re-
cent years, the standard treatment for aggressive gastric
lymphoma has shifted from surgery to chemotherapy.
However, gastrectomy should be considered if a giantulcer and necrotic matter on the ulcer floor are present
on upper gastrointestinal endoscopy because of the possi-
bility of gastric perforation. If upper gastrointestinal en-
doscopy shows a finding similar to the abovementioned
one during chemotherapy, dose reduction of chemother-
apy or gastrectomy should be considered.
In conclusion, a case of spontaneous perforation of
primary gastric malignant lymphoma was reported and
the literature was reviewed. Further research and exam-
ination of similar cases are required to confirm this
relationship (the indication of surgery and pathological
findings), and further assessment of the clinical signifi-
cance of spontaneous perforation of primary gastric
lymphoma is needed.
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